Results 131 to 140 of about 8,031 (177)
Some of the next articles are maybe not open access.

Tumor extracellular triglycerides in mice during growth of ehrlich ascites carcinoma

Lipids, 1975
AbstractOur earlier work with Swiss‐Webster mice has shown that most of the lipid in Ehrlich ascites tumor extracellular fluid is in the form of free fatty acids. This finding is in direct contradiction to earlier and subsequent reports from another laboratory that has found free fatty acids to be a very minor component and triglycerides to be the ...
Kannan, R, Baker, N
openaire   +2 more sources

Tumor-Specific Changes in Mouse Serum during Ehrlich Carcinoma Growth

Bulletin of Experimental Biology and Medicine, 2003
Using the method of flow cytofluorometry we found that proteinase activity eliminating antigenic determinants from the surface of tumor cells disappeared from the serum of mice with Ehrlich carcinoma. This activity towards Ehrlich carcinoma cells is present in the sera of mice without tumors and in mice with other transplanted tumors.
S M, Sitdikova   +3 more
openaire   +2 more sources

Utilization of pyrimidine precursors in tumors and liver of mice with ehrlich's ascites carcinoma

Bulletin of Experimental Biology and Medicine, 1970
Investigation of the incorporation of labeled pyrimidine precursors into free pyrimidine nucleotides, RNA, and DNA of the liver and tumor cells from mice with Ehrlich's ascites carcinoma showed that the incorporation of C14-uridine and C14-orotic acid into the liver of tumor-carrying animals is reduced compared with that into the liver of healthy ...
N. A. Fedorov   +2 more
openaire   +1 more source

Antitumor activity of sitagliptin and vitamin B12 on Ehrlich ascites carcinoma solid tumor in mice

Journal of Biochemical and Molecular Toxicology, 2020
AbstractThis study was carried out to investigate the potential effects of vitamin B12 and sitagliptin, and their possible synergistic effect with doxorubicin (DOX) on the Ehrlich solid tumor model. B12, sitagliptin, and their combination with DOX were administered to tumor‐bearing mice for 21 days.
Rania Salah   +3 more
openaire   +2 more sources

Anticarcinogenic Effect of Commiphora molmol on Solid Tumors Induced by Ehrlich Carcinoma Cells in Mice

Chemotherapy, 2009
The anticarcinogenic potential of Commiphora molmol (oleo-resin) was studied in Ehrlich-solid-tumor-bearing mice. The antitumor activity of C. molmol was evaluated from the total count and viability of Ehrlich solid tumor cells and their nucleic acid, protein, malondialdehyde and glutathione levels at the end of 25 and 50 days of treatment. Furthermore,
M M, al-Harbi   +5 more
openaire   +2 more sources

[The effect of ascitic fluid on the growth of Ehrlich tumor and Lewis carcinoma].

Biulleten' eksperimental'noi biologii i meditsiny, 1993
In the study of the effect of ascitic fluid and dialysate of Ehrlich ascites tumor cells (m.m. less than 15 kDa) on the growth of Ehrlich and Lewis carcinoma it was found that the ascitic fluid significantly decreased the size of Ehrlich tumor (by more than 50% on day 9-25 after the tumor cell inoculation).
F V, Donenko, A O, Kabieva, L V, Moroz
openaire   +1 more source

Anti-Tumor Activity of Ovothiol-A Against Ehrlich Ascites Carcinoma in Mice

Current Chemical Biology
Introduction: Cancer is the second most common cause of death worldwide. Ovothiol-A is an anti-inflammatory and antioxidant compound found in nature. The purpose of the current study is to examine Ovothiol-A's ability to protect against Ehrlich Ascites Cancer (EAC).
Eslam Ibrahim Ahmed Mohamed   +3 more
openaire   +1 more source

Metabolic changes of lymphocytes and neoplastic cells in mice with Ehrlich ascites carcinoma during tumor growth

Biology Bulletin, 2007
Changes in the activities of NAD+- and NADP-dependent dehydrogenases of lymphocytes and tumor cells were studied in mice with Ehrlich ascites carcinoma, as well as changes in the concentrations of oxaloacetate, lactate, and NAD+ in the course of tumor growth.
E V, Inzhevatkin   +3 more
openaire   +2 more sources

Anti-tumor efficacy of glutaminase–copper–ATP combination in mice bearing Ehrlich ascites carcinoma

Anti-Cancer Drugs, 1994
Glutaminase is a hematotoxic anti-tumor agent, and copper-ATP complex (Cu-ATP) is both anti-neoplastic and hematostimulatory. Combination chemotherapy with these two agents has been performed in mice bearing Ehrlich ascites carcinoma, to elucidate whether this could result in augmented tumor inhibition with reduced hematotoxicity.
S, Pal, P, Maity
openaire   +2 more sources

The metabolic changes in tumor-associated macrophages during cancer grow in mice with Ehrlich ascites carcinoma

Doklady Biochemistry and Biophysics, 2017
In this work, we investigated the activity of the key NAD(P)-dependent dehydrogenases associated with macrophage tumors in mice with Ehrlich ascites carcinoma. It was shown that cancer grow is associated with the development of conditions in macrophages leading to a decrease in the substrate flow intensity in the tricarboxylic acid cycle, deceleration ...
E V, Inzhevatkin, A A, Savchenko
openaire   +2 more sources

Home - About - Disclaimer - Privacy